Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
ECONAZOLE NITRATE
Janssen-Cilag Ltd
150mg Milligram
Pessary
1993-01-12
IRISH MEDICINES BOARD ACTS 1995 AND 2006 MEDICINAL PRODUCTS(CONTROL OF PLACING ON THE MARKET)REGULATIONS,2007 (S.I. NO.540 OF 2007) PA0748/017/003 Case No: 2066954 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to JANSSEN-CILAG LTD 50-100 HOLMERS FARM WAY, HIGH WYCOMBE, BUCKINGHAMSHIRE, HP12 4EG, UNITED KINGDOM an authorisation, subject to the provisions of the said Regulations, in respect of the product GYNO-PEVARYL 150 MG VAGINAL PESSARIES The particulars of which are set out in Part I and Part II of the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 09/03/2010. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 15/03/2010_ _CRN 2066954_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Gyno-Pevaryl 150 mg Vaginal Pessaries 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each pessary contains 150 mg Econazole Nitrate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Pessary The pessaries are white to off white and torpedo shaped. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the treatment of fungal or yeast infections of the vagina and vulva. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For vaginal use. One pessary to be inserted deep into the vagina daily for three consecutive days. 4.3 CONTRAINDICATIONS Hypersensitivity to any imidazole preparation or Read the complete document